N
Nepa AB
STO:NEPA
Nepa AB
STO:NEPA
Price:
17.55
SEK
-0.85%
Market Closed
Market Cap:
kr137.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nepa AB
STO:NEPA
|
SE |
|
Electrolux AB
OTC:ELUXY
|
SE |
|
Connexa Sports Technologies Inc
NASDAQ:YYAI
|
US |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
SA |
|
Whirlpool China Co Ltd
SSE:600983
|
CN |
|
F
|
Financeira Alfa SA CFI
BOVESPA:CRIV4
|
BR |
|
I
|
Innovita Biological Technology Co Ltd
SSE:688253
|
CN |
Balance Sheet
Balance Sheet Decomposition
Nepa AB
Nepa AB
Balance Sheet Decomposition is not available for
Nepa AB
Nepa AB
Balance Sheet
Nepa AB
Nepa AB
Currency: SEK
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
4
|
4
|
55
|
23
|
45
|
15
|
70
|
85
|
64
|
38
|
41
|
15
|
|
| Cash Equivalents |
4
|
4
|
55
|
23
|
45
|
15
|
70
|
85
|
64
|
38
|
41
|
15
|
|
| Total Receivables |
4
|
27
|
35
|
51
|
55
|
69
|
54
|
67
|
79
|
66
|
60
|
43
|
|
| Accounts Receivables |
3
|
25
|
33
|
47
|
50
|
64
|
51
|
65
|
76
|
60
|
51
|
39
|
|
| Other Receivables |
0
|
2
|
2
|
4
|
5
|
5
|
4
|
2
|
3
|
6
|
9
|
4
|
|
| Other Current Assets |
1
|
2
|
6
|
5
|
11
|
18
|
11
|
12
|
19
|
19
|
14
|
9
|
|
| Total Current Assets |
8
|
33
|
96
|
79
|
111
|
101
|
135
|
164
|
162
|
123
|
115
|
66
|
|
| PP&E Net |
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Intangible Assets |
0
|
5
|
12
|
21
|
26
|
32
|
30
|
31
|
47
|
55
|
42
|
28
|
|
| Note Receivable |
0
|
0
|
2
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
3
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
8
N/A
|
42
+424%
|
111
+165%
|
101
-8%
|
138
+36%
|
134
-3%
|
167
+25%
|
197
+18%
|
211
+7%
|
179
-15%
|
158
-12%
|
98
-38%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
15
|
21
|
24
|
34
|
47
|
45
|
51
|
53
|
48
|
53
|
31
|
|
| Accrued Liabilities |
2
|
5
|
12
|
17
|
19
|
23
|
28
|
28
|
33
|
33
|
20
|
24
|
|
| Short-Term Debt |
2
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
3
|
11
|
6
|
10
|
10
|
12
|
29
|
14
|
15
|
12
|
10
|
10
|
|
| Total Current Liabilities |
9
|
39
|
40
|
51
|
63
|
83
|
102
|
94
|
101
|
93
|
83
|
65
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
10
N/A
|
39
+304%
|
40
+3%
|
51
+29%
|
63
+23%
|
83
+32%
|
102
+22%
|
94
-8%
|
101
+8%
|
93
-9%
|
83
-10%
|
65
-22%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
2
|
6
|
17
|
48
|
68
|
98
|
84
|
15
|
7
|
31
|
42
|
86
|
|
| Additional Paid In Capital |
0
|
8
|
78
|
79
|
118
|
116
|
115
|
115
|
115
|
115
|
115
|
115
|
|
| Other Equity |
0
|
0
|
8
|
18
|
24
|
30
|
32
|
1
|
0
|
1
|
0
|
3
|
|
| Total Equity |
2
N/A
|
3
N/A
|
71
+2 265%
|
50
-29%
|
75
+49%
|
50
-33%
|
65
+29%
|
103
+58%
|
110
+7%
|
86
-21%
|
75
-14%
|
34
-55%
|
|
| Total Liabilities & Equity |
8
N/A
|
42
+424%
|
111
+165%
|
101
-8%
|
138
+36%
|
134
-3%
|
167
+25%
|
197
+18%
|
211
+7%
|
179
-15%
|
158
-12%
|
98
-38%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
6
|
6
|
7
|
7
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
|
Switch to:
Switch to:
See Also
Discover More
